Caliber Wealth Management (Kansas)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,257
Closed -$336K 260
2025
Q2
$336K Buy
7,257
+3,549
+96% +$174K 0.04% 221
2025
Q1
$226K Buy
+3,708
New +$216K 0.03% 225

Other funds holding BMY

Caliber Wealth Management (Kansas)'s BMY Position: Q3 2025 in Review

Caliber Wealth Management (Kansas) sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 7,257 shares — an estimated $336K sold.

Caliber Wealth Management (Kansas) first reported a position in BMY in Q1 2025 and held it in 2 quarters. The position peaked at $336K in Q2 2025. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Caliber Wealth Management (Kansas) reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Caliber Wealth Management (Kansas) sold 7,257 Bristol-Myers Squibb shares in Q3 2025, an estimated $336K.
  • Caliber Wealth Management (Kansas) first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 2 quarters.
  • Caliber Wealth Management (Kansas)'s Bristol-Myers Squibb position peaked at $336K in Q2 2025.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Caliber Wealth Management (Kansas)'s 13F filing for Q3 2025, filed 5 Nov 2025.